What is Foundayo?
Foundayo is the brand name for orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly.
Unlike injectable GLP-1 medicines, Foundayo is taken by mouth as a tablet. It acts on GLP-1 receptors involved in appetite regulation, helping to reduce hunger and support weight management alongside dietary changes and physical activity.
Foundayo is intended for eligible adults as part of a broader weight management approach. It is not suitable for everyone, and a clinician must assess individual medical history, current medicines and treatment risks before prescribing.
As with other weight-loss medicines, results vary. Medication does not replace the importance of maintaining a balanced diet, regular physical activity and sustainable lifestyle habits.